The National Times - UN touts panel for 'human control' of AI as leaders weigh message

UN touts panel for 'human control' of AI as leaders weigh message


UN touts panel for 'human control' of AI as leaders weigh message

A new UN panel on artificial intelligence aims to "make human control a technical reality", the global body's chief said Friday as leaders at a New Delhi summit weighed their message on the future of the divisive technology.

Change text size:

The flip side of the gold rush surrounding AI is the risk of job disruption, online abuse and the heavy electricity consumption of data centres.

"We are barrelling into the unknown," UN chief Antonio Guterres told the AI Impact Summit in New Delhi, which wraps up later Friday. "The message is simple: Less hype, less fear. More facts and evidence."

The United Nations General Assembly has confirmed 40 members for a new group called the Independent International Scientific Panel on Artificial Intelligence, he said.

The advisory body -- aiming to be to AI what the UN's Intergovernmental Panel on Climate Change (IPCC) is to global warming -- was created in August.

"Science-led governance is not a brake on progress" but can make technological development "safer, fairer, and more widely shared", Guterres said.

"When we understand what systems can do -- and what they cannot -- we can move from rough measures to smarter, risk-based guardrails."

Dozens of world leaders and ministers are expected to deliver on Friday a shared view on the risks and opportunities posed by AI to cap the five-day summit.

It is the fourth annual global meeting focused on AI policy, and the next one will take place in Geneva in the first half of 2027, the Swiss president said on Thursday.

The Delhi gathering is the first AI summit in a developing country, with India taking the opportunity to push its ambitions to catch up with the United States and China.

India expects more than $200 billion in investments over the next two years, and US tech titans unveiled new deals and infrastructure projects this week.

- 'Common good' -

OpenAI's Sam Altman, who leads the company behind ChatGPT, has called for oversight in the past but said last year that taking too tight an approach could hold the United States back in the AI race.

"Centralisation of this technology, in one company or country, could lead to ruin," he said Thursday, one of several top tech CEOs to take the stage.

"This is not to suggest that we won't need any regulation or safeguards. We obviously do, urgently, like we have for other powerful technologies."

But the broad focus of the New Delhi event, and vague promises made at the previous summits in France, South Korea and Britain, could make concrete commitments unlikely.

Even so, "governance of powerful technologies typically begins with shared language: what risks matter, what thresholds are unacceptable", said Niki Iliadis, director of global AI governance at The Future Society.

"It's true that AI companies are influential, but they are not sovereign," she told AFP.

Discussions at the Delhi summit, attended by tens of thousands from across the AI industry, have covered big topics from child protections to the need for more equal access to AI tools worldwide.

"We are entering an era where humans and intelligence systems co-create, co-work and co-evolve," Indian Prime Minister Narendra Modi said on Thursday.

"We must resolve that AI is used for the global common good."

India also formally joined a US-led "Pax Silica" initiative aimed at "about building supply chains that will not be held hostage" at securing AI supply, Jacob Helberg, US Under Secretary of State for Economic Affairs, told the summit.

A.Davey--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: